Method Of Treatment Of Complement Mediated Neurodevelopmental Disorder Secondary To Zika Virus Infection

Abstract

The present invention relates to methods of treating or preventing complement mediated neurodevelopmental disorders secondary to maternal infection with Zika virus, comprising administering to a pregnant female or to a foetus or embryo, a therapeutically or prophylactically effective amount of an agent which is a protein comprising amino acids 19 to 168 of the amino acid sequence in Figure 2 (SEQ ID NO: 2) or a functional equivalent of this protein.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 24, 2017
  • Application: Feb 17, 2017
    WO EP 2017053714 W
  • Priority: Feb 17, 2016
    GB GB 201602802 A

Download Citation


Sign in to the Lens

Feedback